🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could lead to individuals injecting products of unknown origin.

Some experts said the popularity for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Elimination

According to the social media company, the platform has taken down problematic content and banned associated hashtags and search suggestions. The company said it was committed to keeping the service safe and investing in enhancing compliance measures.

Online Marketplace Activities

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with images of weight loss, positive testimonials and detailed guides for preparing or administering at residence.

Within moments of joining one community, a seller posted contact information, where the majority of transactions occur. The vendor sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, medical conditions or past usage.

Item Details and Pricing

Inside these communities, messages display black plastic parcels with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has already seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to potentially significant health risks”.